Anthropic's IPO Price Fight: $1.5 Trillion or $2 Trillion?
Anthropic, PBC is aiming to stage its initial public offering the week before Thanksgiving, and the Wall Street Journal reports the offering could raise up to $100 billion. The price is the sticking point. Investors who had expected a valuation of around $2 trillion, as the Journal reported in September, are now pushing for a lower figure. Institutional investors, meaning large funds that buy stock in bulk, are urging a target of $1.5 trillion to $1.6 trillion.
Two terms matter here. Valuation is the price the company's equity is set at, and offering size is how much of that equity gets sold. On those two figures alone, a $100 billion raise at a $1.5 trillion valuation would mean selling roughly 6.7 percent of the company. A lower price gives new buyers a larger stake for each dollar, and it leaves less room for the kind of first-day gain that tends to draw headlines.
The deal has moved through a set of disclosed steps. Anthropic confidentially submitted a draft S-1 to the SEC on June 1, 2026, and said the proposed offering would depend on market conditions and other factors. An S-1 is the registration statement a company files with the Securities and Exchange Commission before selling shares to the public. Bloomberg reported on October 1 that the company was seeking to go public as soon as the middle of November. The public S-1 followed on October 26, which proposed listing its Class A common stock on the Nasdaq Global Select Market under the ticker "ANT." An amended S-1/A-1 was filed with the SEC on November 2.
The last priced private round is the reference point most investors will use. In February, Anthropic raised $30 billion in Series G funding led by GIC and Coatue at a $380 billion post-money valuation. Moving from that mark to $1.5 trillion is a multiple of roughly four times in a single step. The $2 trillion figure would be about five times the Series G valuation.
In my view, that step-up is the central question. Public-market investors will weigh it against revenue growth, margins, and the company's capital needs, none of which are captured by the headline valuation alone.
Anthropic flagged catastrophic AI risks in its IPO filing at the end of September. Issuers must describe material risks, so the disclosure is standard in that sense.
The broader context here is that for an AI developer the risk category is unusually broad. That gives skeptical buyers a specific list to point to when they argue for a lower price.
The timing risk is now explicit. Reuters reported on November 5 that potential investors said AI backlash could threaten Anthropic's IPO timing. Some of those investors view the $1.5 trillion valuation that has been discussed as high, and they are pressing for a more attractive entry price before committing to the offering.
The question of who benefits is still open. A lower valuation would be easier for institutional buyers to underwrite, and a higher one would favor existing holders. For ordinary savers, the more practical question is whether pension and index funds that eventually hold the stock will pay the price the IPO prices at, rather than the price it trades at after the first weeks.
The company has said the deal is contingent on conditions outside its control. Until pricing is set, the $1.5 trillion to $1.6 trillion range is an investor target reported by the press, not an agreed number. The week-before-Thanksgiving date is a stated aim, not a booked calendar slot.
